Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: A single institution pilot study

Journal of Hospital Infection

Volumn 84, Issue 1, 2013, Pages 85-88

  Bertoglio, S ^a,b   Rezzo, R ^a   Merlo, F D ^b   Solari, N ^a   Palombo, D ^a   Vassallo, F ^b   Beltramini, S ^b   DeMaria, A ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Central venous system; Equipment contamination; Infusion; Microbiology; Syringes; Totally implantable venous access devices

Indexed keywords

SODIUM CHLORIDE;

ARTICLE; CANCER STAGING; CATHETER INFECTION; COHORT ANALYSIS; DEVICE INFECTION; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; NEOPLASM; OBSERVATIONAL STUDY; PILOT STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SYRINGE; TOTALLY IMPLANTABLE VENOUS ACCESS DEVICE; VASCULAR ACCESS;

ADULT; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS; PILOT PROJECTS; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHLORIDE; SYRINGES;

EID: 84876312943     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.02.008     Document Type: Article

References (10)

1. Bishop L., Dougherty L., Bodenham A., et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol 2007, 29:261-278.
2. Bertoglio S., Solari N., Meszaros P., et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs 2012, 35:E35-E42.
3. Trautmann M., Zauser B., Wiedeck H. Bacterial colonisation and endotoxin contamination of intravenous infusion fluids. J Hosp Infect 1997, 37:225-236.
4. van Grafhorst J.P., Foudraine N.A., Nooteboom F., Crombach W.H., Oldenhof N.J., van Doorn H. Unexpected high risk of contamination with staphylococci species attributable to standard preparation of syringes for continuous intravenous drug administration in a simulation model in intensive care units. Crit Care Med 2002, 30:833-836.
5. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011, 39(4 Suppl. 1):S1-34.
6. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
7. Pratt R.J., Pellowe C.M., Wilson J.A., et al. epic-2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65(Suppl. 1):S1-S64.
8. Pearson M.L. Guideline for prevention of intravascular device-related infections. Infect Control Hosp Epidemiol 1996, 17:438-473. Hospital Infection Control Practices Advisory Committee.
9. Kim J.S., Holtom P., Vigen C. Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control 2011, 39:640-646.
10. Hockenhull J.C., Dwan K., Boland A., et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 2008, 12:1-154.